- Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
- Axonics Reports First Quarter 2024 Financial Results
- Axonics Stockholders Approve Merger Agreement with Boston Scientific
- Axonics Provides Update on Inter Partes Review Proceedings
- Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
- Axonics Responds to ITC Action by Medtronic
- Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
More ▼
Key statistics
On Friday, Axonics Inc (AXNX:NSQ) closed at 67.22, -3.52% below its 52-week high of 69.68, set on Jan 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 67.50 |
---|---|
High | 67.50 |
Low | 67.12 |
Bid | 67.21 |
Offer | 67.23 |
Previous close | 67.33 |
Average volume | 334.15k |
---|---|
Shares outstanding | 51.02m |
Free float | 50.47m |
P/E (TTM) | -- |
Market cap | 3.44bn USD |
EPS (TTM) | -0.3134 USD |
Data delayed at least 15 minutes, as of May 24 2024 20:52 BST.
More ▼